Industry: Food & Beverages
Published Date: 2025-12-02
Pages: 125 Pages
Report ld: 4341170
Request Sample
Customized Report
Infant Formula Market Size(US$)

CAGR 2025-2031
3.1%
Market Size,2031
USD 36,746
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Infant Formula was valued at US$ 29752 million in the year 2024 and is projected to reach a revised size of US$ 36746 million by 2031, growing at a CAGR of 3.1% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Infant Formula competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
In 2024, global Infant Formula production reached approximately 2,118.51 K MT, with an average global market price of around US$ 14,200 per MT.
Infant Formula is a specially designed powdered formula food for infants, intended to partially or completely replace breast milk when needed. It is typically based on cow’s milk or other dairy proteins, with carefully adjusted levels of fats, carbohydrates, vitamins, minerals and essential micronutrients to meet the nutritional requirements of early growth and development. Produced under strict food safety and regulatory standards, infant formula must be registered or approved by competent authorities, ensuring its composition is safe, digestible and nutritionally appropriate, and providing a consistent, controllable source of nutrition for babies who cannot be exclusively breastfed or require formula feeding.
Market Development Opportunities & Main Driving Factors
Globally, the Infant Formula market continues to show solid growth, supported by ongoing urbanization, a rising share of working mothers and growing awareness of the "first 1,000 days" as a critical nutrition window. Leading players report that infant nutrition businesses are delivering mid- to high single-digit growth, with premium offerings such as formulas enriched with Human Milk Oligosaccharides (HMOs), prebiotics, organic and A2 variants driving mix upgrade and margin expansion. In emerging markets, infant formula remains central to improving early-life nutrition, with multinational and local brands expanding reach through differentiated formulations, strong presence in mother-and-baby specialty stores and increasing e-commerce penetration. At the same time, a number of governments facing declining birth rates are introducing childcare subsidies and even free-milk initiatives, which help ease the cost of raising children and support medium- to long-term demand expectations for infant nutrition categories.
Market Challenges, Risks, & Restraints
The industry also faces structural headwinds related to demographics, regulation and competition. In many developed economies and in key markets such as China, the number of newborns has been trending down, putting pressure on baseline demand for standard formulas, and several companies have publicly acknowledged volume declines in their China infant formula business. Meanwhile, regulators are tightening rules on formula registration, on-pack claims, cross-border trade and quality control, pushing formulations toward simplification while raising R&D and compliance costs. Any safety incident or recall can quickly escalate into a serious brand and channel crisis. Competitive intensity remains high, with global giants, strong domestic champions and regional brands all vying for share in organic, premium and specialized segments. Price warfare and aggressive promotions still occur, and the high transparency of online pricing further squeezes margins, especially for mid- and low-tier brands.
Downstream Demand Trends
On the demand side, the market is characterized by relatively stable or slowing volumes but clear value-mix upgrading. Even as birth numbers soften, parents are willing to spend more per child on safety and science-backed nutrition, accelerating the shift toward premium, organic, A2, HMO/prebiotic-enriched and specialized medical formulas, which are capturing a growing share of category value. Channel dynamics are also evolving: offline mother-and-baby specialty chains remain critical for brand building and professional advisory services, while e-commerce, direct-to-consumer stores and cross-border platforms continue to gain share, with live-streaming and large online campaigns becoming key tools for consumer education and acquisition. Regionally, China is going through a period of destocking and structural adjustment toward more premium and differentiated offerings, while fast-growing Asian, Middle Eastern, African and Latin American markets are contributing incremental volume and value. Looking ahead, companies that can combine rigorous safety and traceability with credible nutrition science, sustainability and truly omnichannel engagement with new-generation parents will be best positioned to build durable competitive advantages in the Infant Formula market.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Infant Formula, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infant Formula.
The Infant Formula market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Infant Formula market comprehensively. Regional market sizes, concerning products by Type, by Application, by Stage and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infant Formula manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Stage and by regions.
By Company
Danone
Nestle
Abbott
Reckiit
Biostime
Bellamy
Topfer
HiPP
Perrigo
Humana
Nutribio
Meiji
a2 Milk
Ausnutria
Feihe
Yili
Yashili
Bright Dairy & Food
Junlebao
Beingmate
Wonder Sun
Wissun
YeePer
Synutra
Mengniu Dairy
Holle
Nestle
Segment by Type
Cow Milk Powder
Goat Milk Powder
Other
Segment by Stage
First Stage
Second Stage
Third Stage
Segment by Source
Regular
Organic
Segment by Price Range
Economy Type
Mid-range Type
High-end Type
Segment by Application
Maternal Stores
Supermarkets/Hypermarkets
Online Retail
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Infant Formula manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Infant Formula in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Infant Formula Market Overview
1.1 Product Definition
1.2 Infant Formula by Type
1.2.1 Global Infant Formula Market Value Comparison by Type (2024 VS 2031)
1.2.2 Cow Milk Powder
1.2.3 Goat Milk Powder
1.2.4 Other
1.3 Infant Formula by Stage
1.3.1 Global Infant Formula Market Value Comparison by Stage: 2024 VS 2031
1.3.2 First Stage
1.3.3 Second Stage
1.3.4 Third Stage
1.4 Infant Formula by Source
1.4.1 Global Infant Formula Market Value Comparison by Source: 2024 VS 2031
1.4.2 Regular
1.4.3 Organic
1.5 Infant Formula by Price Range
1.5.1 Global Infant Formula Market Value Comparison by Price Range: 2024 VS 2031
1.5.2 Economy Type
1.5.3 Mid-range Type
1.5.4 High-end Type
1.6 Infant Formula by Application
1.6.1 Global Infant Formula Market Value by Application (2024 VS 2031)
1.6.2 Maternal Stores
1.6.3 Supermarkets/Hypermarkets
1.6.4 Online Retail
1.6.5 Others
1.7 Global Infant Formula Market Size Estimates and Forecasts
1.7.1 Global Infant Formula Revenue 2020-2031
1.7.2 Global Infant Formula Sales 2020-2031
1.7.3 Global Infant Formula Market Average Price (2020-2031)
1.8 Assumptions and Limitations
2 Infant Formula Market Competition by Manufacturers
2.1 Global Infant Formula Sales Market Share by Manufacturers (2020-2025)
2.2 Global Infant Formula Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Infant Formula Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Infant Formula, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Infant Formula, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Infant Formula, Product Type & Application
2.7 Global Key Manufacturers of Infant Formula, Date of Enter into This Industry
2.8 Global Infant Formula Market Competitive Situation and Trends
2.8.1 Global Infant Formula Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Infant Formula Players Market Share by Revenue
2.8.3 Global Infant Formula Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Infant Formula Market Scenario by Region
3.1 Global Infant Formula Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Infant Formula Sales by Region: 2020-2031
3.2.1 Global Infant Formula Sales by Region: 2020-2025
3.2.2 Global Infant Formula Sales by Region: 2026-2031
3.3 Global Infant Formula Revenue by Region: 2020-2031
3.3.1 Global Infant Formula Revenue by Region: 2020-2025
3.3.2 Global Infant Formula Revenue by Region: 2026-2031
3.4 North America Infant Formula Market Facts & Figures by Country
3.4.1 North America Infant Formula Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Infant Formula Sales by Country (2020-2031)
3.4.3 North America Infant Formula Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Infant Formula Market Facts & Figures by Country
3.5.1 Europe Infant Formula Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Infant Formula Sales by Country (2020-2031)
3.5.3 Europe Infant Formula Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Infant Formula Market Facts & Figures by Region
3.6.1 Asia Pacific Infant Formula Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Infant Formula Sales by Region (2020-2031)
3.6.3 Asia Pacific Infant Formula Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Infant Formula Market Facts & Figures by Country
3.7.1 Latin America Infant Formula Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Infant Formula Sales by Country (2020-2031)
3.7.3 Latin America Infant Formula Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Infant Formula Market Facts & Figures by Country
3.8.1 Middle East and Africa Infant Formula Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Infant Formula Sales by Country (2020-2031)
3.8.3 Middle East and Africa Infant Formula Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Infant Formula Sales by Type (2020-2031)
4.1.1 Global Infant Formula Sales by Type (2020-2025)
4.1.2 Global Infant Formula Sales by Type (2026-2031)
4.1.3 Global Infant Formula Sales Market Share by Type (2020-2031)
4.2 Global Infant Formula Revenue by Type (2020-2031)
4.2.1 Global Infant Formula Revenue by Type (2020-2025)
4.2.2 Global Infant Formula Revenue by Type (2026-2031)
4.2.3 Global Infant Formula Revenue Market Share by Type (2020-2031)
4.3 Global Infant Formula Price by Type (2020-2031)
5 Segment by Application
5.1 Global Infant Formula Sales by Application (2020-2031)
5.1.1 Global Infant Formula Sales by Application (2020-2025)
5.1.2 Global Infant Formula Sales by Application (2026-2031)
5.1.3 Global Infant Formula Sales Market Share by Application (2020-2031)
5.2 Global Infant Formula Revenue by Application (2020-2031)
5.2.1 Global Infant Formula Revenue by Application (2020-2025)
5.2.2 Global Infant Formula Revenue by Application (2026-2031)
5.2.3 Global Infant Formula Revenue Market Share by Application (2020-2031)
5.3 Global Infant Formula Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Danone
6.1.1 Danone Company Information
6.1.2 Danone Description and Business Overview
6.1.3 Danone Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Danone Infant Formula Product Portfolio
6.1.5 Danone Recent Developments/Updates
6.2 Nestle
6.2.1 Nestle Company Information
6.2.2 Nestle Description and Business Overview
6.2.3 Nestle Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Nestle Infant Formula Product Portfolio
6.2.5 Nestle Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Company Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Abbott Infant Formula Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 Reckiit
6.4.1 Reckiit Company Information
6.4.2 Reckiit Description and Business Overview
6.4.3 Reckiit Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Reckiit Infant Formula Product Portfolio
6.4.5 Reckiit Recent Developments/Updates
6.5 Biostime
6.5.1 Biostime Company Information
6.5.2 Biostime Description and Business Overview
6.5.3 Biostime Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Biostime Infant Formula Product Portfolio
6.5.5 Biostime Recent Developments/Updates
6.6 Bellamy
6.6.1 Bellamy Company Information
6.6.2 Bellamy Description and Business Overview
6.6.3 Bellamy Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Bellamy Infant Formula Product Portfolio
6.6.5 Bellamy Recent Developments/Updates
6.7 Topfer
6.7.1 Topfer Company Information
6.7.2 Topfer Description and Business Overview
6.7.3 Topfer Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Topfer Infant Formula Product Portfolio
6.7.5 Topfer Recent Developments/Updates
6.8 HiPP
6.8.1 HiPP Company Information
6.8.2 HiPP Description and Business Overview
6.8.3 HiPP Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.8.4 HiPP Infant Formula Product Portfolio
6.8.5 HiPP Recent Developments/Updates
6.9 Perrigo
6.9.1 Perrigo Company Information
6.9.2 Perrigo Description and Business Overview
6.9.3 Perrigo Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Perrigo Infant Formula Product Portfolio
6.9.5 Perrigo Recent Developments/Updates
6.10 Humana
6.10.1 Humana Company Information
6.10.2 Humana Description and Business Overview
6.10.3 Humana Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Humana Infant Formula Product Portfolio
6.10.5 Humana Recent Developments/Updates
6.11 Nutribio
6.11.1 Nutribio Company Information
6.11.2 Nutribio Description and Business Overview
6.11.3 Nutribio Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Nutribio Infant Formula Product Portfolio
6.11.5 Nutribio Recent Developments/Updates
6.12 Meiji
6.12.1 Meiji Company Information
6.12.2 Meiji Description and Business Overview
6.12.3 Meiji Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Meiji Infant Formula Product Portfolio
6.12.5 Meiji Recent Developments/Updates
6.13 a2 Milk
6.13.1 a2 Milk Company Information
6.13.2 a2 Milk Description and Business Overview
6.13.3 a2 Milk Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.13.4 a2 Milk Infant Formula Product Portfolio
6.13.5 a2 Milk Recent Developments/Updates
6.14 Ausnutria
6.14.1 Ausnutria Company Information
6.14.2 Ausnutria Description and Business Overview
6.14.3 Ausnutria Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Ausnutria Infant Formula Product Portfolio
6.14.5 Ausnutria Recent Developments/Updates
6.15 Feihe
6.15.1 Feihe Company Information
6.15.2 Feihe Description and Business Overview
6.15.3 Feihe Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Feihe Infant Formula Product Portfolio
6.15.5 Feihe Recent Developments/Updates
6.16 Yili
6.16.1 Yili Company Information
6.16.2 Yili Description and Business Overview
6.16.3 Yili Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Yili Infant Formula Product Portfolio
6.16.5 Yili Recent Developments/Updates
6.17 Yashili
6.17.1 Yashili Company Information
6.17.2 Yashili Description and Business Overview
6.17.3 Yashili Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Yashili Infant Formula Product Portfolio
6.17.5 Yashili Recent Developments/Updates
6.18 Bright Dairy & Food
6.18.1 Bright Dairy & Food Company Information
6.18.2 Bright Dairy & Food Description and Business Overview
6.18.3 Bright Dairy & Food Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Bright Dairy & Food Infant Formula Product Portfolio
6.18.5 Bright Dairy & Food Recent Developments/Updates
6.19 Junlebao
6.19.1 Junlebao Company Information
6.19.2 Junlebao Description and Business Overview
6.19.3 Junlebao Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Junlebao Infant Formula Product Portfolio
6.19.5 Junlebao Recent Developments/Updates
6.20 Beingmate
6.20.1 Beingmate Company Information
6.20.2 Beingmate Description and Business Overview
6.20.3 Beingmate Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Beingmate Infant Formula Product Portfolio
6.20.5 Beingmate Recent Developments/Updates
6.21 Wonder Sun
6.21.1 Wonder Sun Company Information
6.21.2 Wonder Sun Description and Business Overview
6.21.3 Wonder Sun Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Wonder Sun Infant Formula Product Portfolio
6.21.5 Wonder Sun Recent Developments/Updates
6.22 Wissun
6.22.1 Wissun Company Information
6.22.2 Wissun Description and Business Overview
6.22.3 Wissun Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Wissun Infant Formula Product Portfolio
6.22.5 Wissun Recent Developments/Updates
6.23 YeePer
6.23.1 YeePer Company Information
6.23.2 YeePer Description and Business Overview
6.23.3 YeePer Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.23.4 YeePer Infant Formula Product Portfolio
6.23.5 YeePer Recent Developments/Updates
6.24 Synutra
6.24.1 Synutra Company Information
6.24.2 Synutra Description and Business Overview
6.24.3 Synutra Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.24.4 Synutra Infant Formula Product Portfolio
6.24.5 Synutra Recent Developments/Updates
6.25 Mengniu Dairy
6.25.1 Mengniu Dairy Company Information
6.25.2 Mengniu Dairy Description and Business Overview
6.25.3 Mengniu Dairy Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.25.4 Mengniu Dairy Infant Formula Product Portfolio
6.25.5 Mengniu Dairy Recent Developments/Updates
6.26 Holle
6.26.1 Holle Company Information
6.26.2 Holle Description and Business Overview
6.26.3 Holle Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.26.4 Holle Infant Formula Product Portfolio
6.26.5 Holle Recent Developments/Updates
6.27 Nestle
6.27.1 Nestle Company Information
6.27.2 Nestle Description and Business Overview
6.27.3 Nestle Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.27.4 Nestle Infant Formula Product Portfolio
6.27.5 Nestle Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Infant Formula Industry Chain Analysis
7.2 Infant Formula Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Infant Formula Production Mode & Process Analysis
7.4 Infant Formula Sales and Marketing
7.4.1 Infant Formula Sales Channels
7.4.2 Infant Formula Distributors
7.5 Infant Formula Customer Analysis
8 Infant Formula Market Dynamics
8.1 Infant Formula Industry Trends
8.2 Infant Formula Market Drivers
8.3 Infant Formula Market Challenges
8.4 Infant Formula Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Infant Formula market is projected to grow from US$ 29889 million in 2025 to US$ 36405 million by 2032, at a CAGR of 2.4% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-01-22
Pages: 217
USD 4900.00
(Single User License)
The global Infant Formula market was valued at US$ 29889 million in 2025 and is anticipated to reach US$ 36405 million by 2032, at a CAGR of 2.4% from 2026 to 2032.
Published Date: 2026-01-22
Pages: 155
USD 2900.00
(Single User License)
The global Infant Formula market size was US$ 29889 million in 2025 and is forecast to reach a readjusted size of US$ 36405 million by 2032 with a CAGR of 2.4% during the forecast period 2026-2032.
Published Date: 2026-01-22
Pages: 130
USD 4250.00
(Single User License)
The global market for Infant Formula was estimated to be worth US$ 29889 million in 2025 and is projected to reach US$ 36405 million, growing at a CAGR of 2.4% from 2026 to 2032.
Published Date: 2026-01-22
Pages: 173
USD 3950.00
(Single User License)
The global Infant Formula market size was US$ 29752 million in 2024 and is forecast to a readjusted size of US$ 36746 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-12-02
Pages: 123
USD 4250.00
(Single User License)
The global market for Infant Formula was estimated to be worth US$ 29752 million in 2024 and is forecast to a readjusted size of US$ 36746 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-12-01
Pages: 174
USD 3950.00
(Single User License)
The global Infant Formula market is projected to grow from US$ 29752 million in 2024 to US$ 36746 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-12-01
Pages: 203
USD 4900.00
(Single User License)
The global market for Infant Formula was estimated to be worth US$ 51600 million in 2024 and is forecast to a readjusted size of US$ 74940 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.
Published Date: 2025-02-27
Pages: 99
USD 3950.00
(Single User License)
The global Infant Formula market is projected to grow from US$ 49140 million in 2024 to US$ 67970 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.6% during the forecast period.
Published Date: 2024-04-26
Pages: 91
USD 4900.00
(Single User License)
The global Infant Formula market was valued at US$ 46350 million in 2023 and is anticipated to reach US$ 67970 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.
Published Date: 2024-01-15
Pages: 86
USD 2900.00
(Single User License)
The global Infant Formula market is projected to grow from US$ 29889 million in 2025 to US$ 36405 million by 2032, at a CAGR of 2.4% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-01-22
Pages: 217
The global Infant Formula market was valued at US$ 29889 million in 2025 and is anticipated to reach US$ 36405 million by 2032, at a CAGR of 2.4% from 2026 to 2032.
Published: 2026-01-22
Pages: 155
The global Infant Formula market size was US$ 29889 million in 2025 and is forecast to reach a readjusted size of US$ 36405 million by 2032 with a CAGR of 2.4% during the forecast period 2026-2032.
Published: 2026-01-22
Pages: 130
The global market for Infant Formula was estimated to be worth US$ 29889 million in 2025 and is projected to reach US$ 36405 million, growing at a CAGR of 2.4% from 2026 to 2032.
Published: 2026-01-22
Pages: 173
The global Infant Formula market size was US$ 29752 million in 2024 and is forecast to a readjusted size of US$ 36746 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-12-02
Pages: 123
The global market for Infant Formula was estimated to be worth US$ 29752 million in 2024 and is forecast to a readjusted size of US$ 36746 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-12-01
Pages: 174
The global Infant Formula market is projected to grow from US$ 29752 million in 2024 to US$ 36746 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-12-01
Pages: 203
The global market for Infant Formula was estimated to be worth US$ 51600 million in 2024 and is forecast to a readjusted size of US$ 74940 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.
Published: 2025-02-27
Pages: 99
The global Infant Formula market is projected to grow from US$ 49140 million in 2024 to US$ 67970 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.6% during the forecast period.
Published: 2024-04-26
Pages: 91
The global Infant Formula market was valued at US$ 46350 million in 2023 and is anticipated to reach US$ 67970 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.
Published: 2024-01-15
Pages: 86
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now